Search research articles
Contact Us
Filters
Showing results (301-310 of 351) with videos related to
Page
of 36
Sort By:
Cancers
|
November 25, 2023
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating <i>EGFR</i> Exon 20 Insertion Mutations
Petros Christopoulos, Nicolas Girard, Claudia Proto, et al.
Clinical Drug Investigation
|
November 25, 2021
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Katja Weisel, Thomas Martin, Amrita Krishnan, et al.
Cancers
|
December 10, 2021
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry
Maximilian Merz, Hartmut Goldschmidt, Parameswaran Hari, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
January 13, 2025
Egg allergen-specific T-cell and cytokine responses in healthy and egg-allergic children naturally tolerating baked egg
Liselot De Vlieger, Lisa Nuyttens, Cheyenne Keppens, et al.
Scientific Reports
|
November 8, 2016
Sustained synchronized neuronal network activity in a human astrocyte co-culture system
Jacobine Kuijlaars, Tutu Oyelami, Annick Diels, et al.
Hemasphere
|
December 8, 2022
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
Michel Delforge, Marie-Christiane Vekemans, Julien Depaus, et al.
Cancer Treatment and Research Communications
|
July 21, 2024
A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion-mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study
Nicolas Girard, Keunchil Park, Se-Hoon Lee, et al.
Current Medical Research and Opinion
|
October 22, 2022
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
Tom Martin, Saad Z Usmani, Jordan M Schecter, et al.
Leukemia & Lymphoma
|
January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study
Paula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.
Scientific Reports
|
August 16, 2019
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
Gabriela Torrea, Kamela C S Ng, Armand Van Deun, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 351) with videos related to
Sort By:
Page
of 36
Cancers
|
November 25, 2023
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating <i>EGFR</i> Exon 20 Insertion Mutations
Petros Christopoulos, Nicolas Girard, Claudia Proto, et al.
Clinical Drug Investigation
|
November 25, 2021
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Katja Weisel, Thomas Martin, Amrita Krishnan, et al.
Cancers
|
December 10, 2021
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry
Maximilian Merz, Hartmut Goldschmidt, Parameswaran Hari, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
January 13, 2025
Egg allergen-specific T-cell and cytokine responses in healthy and egg-allergic children naturally tolerating baked egg
Liselot De Vlieger, Lisa Nuyttens, Cheyenne Keppens, et al.
Scientific Reports
|
November 8, 2016
Sustained synchronized neuronal network activity in a human astrocyte co-culture system
Jacobine Kuijlaars, Tutu Oyelami, Annick Diels, et al.
Hemasphere
|
December 8, 2022
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
Michel Delforge, Marie-Christiane Vekemans, Julien Depaus, et al.
Cancer Treatment and Research Communications
|
July 21, 2024
A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion-mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study
Nicolas Girard, Keunchil Park, Se-Hoon Lee, et al.
Current Medical Research and Opinion
|
October 22, 2022
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
Tom Martin, Saad Z Usmani, Jordan M Schecter, et al.
Leukemia & Lymphoma
|
January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study
Paula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.
Scientific Reports
|
August 16, 2019
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
Gabriela Torrea, Kamela C S Ng, Armand Van Deun, et al.
Page
of 36